共 114 条
[1]
Nathan DM(2009)Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193-203
[2]
Buse JB(1996)Metformin N Engl J Med 334 574-579
[3]
Davidson MB(2009)Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus Clin Pharmacol Ther 85 513-519
[4]
Ferrannini E(2009)Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects Clin Pharmacol Ther 85 520-526
[5]
Holman RR(2009)Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes Diabetes Care 32 650-657
[6]
Sherwin R(2009)A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment Diabetes Care 32 1656-1662
[7]
Zinman B(2005)Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes Diabetes 54 3427-3434
[8]
Bailey CJ(2010)Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial Diabetes Care 33 2217-2224
[9]
Turner RC(2010)Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial Lancet 375 2223-2233
[10]
Komoroski B(2011)Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomised, 24-week, double-blind, placebo-controlled trial Diabetes Obes Metab 13 928-938